Hummingbird, Sanofi to develop cancer antibodies

Hummingbird Bioscience Pte. Ltd. (Singapore) said it partnered with Sanofi (Euronext:SAN; NYSE:SNY) to develop therapeutic antibodies in oncology using Hummingbird's Rational Antibody Design technology. Hummingbird CEO Piers Ingram declined to disclose financial terms or targets for the collaboration. ...